Skip to main content

InspireMD, Inc.

NSPR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001433607

No open-market purchases or sales by InspireMD, Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $15.1M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding InspireMD, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of NSPR: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders2116−5
SharesConverted for a 1-for-15 split467.1K450.8K−16.2K (−3.5%)
Value$4.72M$2.27M−$2.45M (−51.8%)

New holders (3)

Institutions that held InspireMD, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to NSPR in Q2 2021
InstitutionSharesValue% of portfolio
Hollencrest Capital Management20,000$101.0K0.01%
Susquehanna Fundamental Investments, LLC17,901$90.0K0.00%
Goldman Sachs Group Inc16,832$85.0K0.00%

Sold out (8)

Institutions that held InspireMD, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of NSPR in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Jane Street Group, LLC112,002$75.0K
United Asset Strategies, Inc.70,000$47.0K
Tobias Financial Advisors, Inc.40,000$27.0K
Two Sigma Securities, LLC37,615$25.0K
Commonwealth Equity Services, LLC36,000$24.0K
Raymond James & Associates35,000$24.0K
Citigroup Inc3,000$2.00K
Bank of America Corp600$0